AEDFF Earnings Beat: Aedifica SA Q2 2026 Results

Aedifica SA (AEDFF) delivered solid Q2 2026 earnings results on (May 19, 2026), posting $1.53 EPS and $130.99M in revenue. The healthcare real estate investment trust (REIT) showed strong operational performance compared to prior quarters. This earnings recap breaks down what the results mean for AEDFF stock and investors tracking this European healthcare property specialist.

AEDFF Earnings Preview: EPS and Revenue Expectations

Aedifica SA reported $1.53 EPS for Q2 2026, a significant jump from the prior quarter’s $1.15 EPS. Revenue climbed to $130.99M, up from $106.06M in the previous quarter. The company showed 33% quarter-over-quarter EPS growth, demonstrating improved profitability in its European healthcare property portfolio. Strong rental income from indexed leases drove the performance.

Aedifica SA Stock Valuation and Key Financial Metrics

AEDFF trades at $80.22 with a $3.81B market cap and 6.01 PE ratio, suggesting attractive valuation for income investors. The stock offers a 5.8% dividend yield, well above market averages. Book value per share stands at $77.14, indicating the stock trades near tangible asset value. Strong interest coverage of 6.18x shows the REIT can comfortably service its debt obligations.

What to Watch in Aedifica SA Earnings Report

AEDFF stock showed 0% price movement on earnings day, suggesting the market had priced in the results. The company maintains a B+ grade from Meyka AI, reflecting solid fundamentals and neutral outlook. Investors should monitor European healthcare real estate demand and interest rate trends. The REIT’s focus on elderly care facilities positions it well in aging demographics.

AEDFF Stock Forecast and Analyst Outlook

Analysts rate AEDFF as a BUY with one positive recommendation. The stock trades 10% below its 52-week high of $87.78, offering entry opportunity. Meyka AI forecasts $95.18 quarterly price target and $96.35 five-year target. The company’s recurring rental income model and European market exposure support long-term growth potential.

Final Thoughts

Aedifica SA’s Q2 2026 earnings demonstrated strong quarter-over-quarter growth with $1.53 EPS and $130.99M revenue, marking solid execution in European healthcare real estate. The AEDFF stock’s B+ rating and attractive 5.8% dividend yield make it appealing for income-focused investors seeking real estate exposure. With valuation near book value and analyst support, the REIT appears well-positioned for continued performance in the healthcare property sector.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.